The fight against cholesterol is all set to get a new weapon. A new class of injectable drugs which has shown to dramatically lower cholesterol has been recommended by the FDA advisory panel and could hit the market within 2 years.
In the medical world, this is a pretty big deal because not only are these drugs effective and low on side-effects, but are also the first line of medication to be developed for lowering LDL or bad cholesterol in nearly 3 decades.
Read Latest News and Breaking News at The Quint, browse for more from fit
Topics: Pharmaceuticals US FDA Cholesterol
Published:


